Compta and co-authors used RT-QuIC to measure CSF α-synuclein levels, in conjunction with CSF NfL and the midbrain-to-pons ratio, in patients with PSP, CBD, PD, and MSA and in healthy controls [109]. This evidence concerns the gene SNCG and supranuclear palsy, progressive, 1.